Loading stock data…
Freenome, Inc. (FRNM)
$15.99-0.32 (-1.96%)
Market ClosedLast close Sep 8
Freenome, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Freenome, Inc. in the Healthcare sector is trading at $15.99 with a market capitalization of $1.7B. Wall Street consensus targets $18.00 (5 analysts), implying a +12.6% move over the next 12 months. The stock is currently near its 52-week high of $17.18, remaining 32.5% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +12.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 |
|---|---|
| Total Revenue | $30.41M |
| Gross Profit | $28.46M |
| Operating Income | -$223.47M |
| Net Income | -$219.34M |
Peer Comparison
JNJUNHPFE
Fundamentals
Freenome, Inc. operates as a biotechnology company in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.72B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.48
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
540,575
Recent News
Freenome (FRNM) Climbed, But What Is Driving Attention Now?
Freenome stock reaction and recent performance snapshot Freenome (FRNM) has drawn fresh investor attention following its recent share price move, with the stock last closing at $11.62. This puts the company’s market value at about $1.26b. Over the past month, Freenome’s share price return is 7.59%, while the past 3 months show a 2.83% gain. The stock’s 1 year total return stands at 9.93%, and the year to date performance reflects a decline of 10.62%. Freenome reported revenue of $34.24m,...
Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook
Guardant Health is Thursday's IBD Stock Of The Day in a thriving market for colon cancer screening tests. On Friday, Guardant Health stock surged after the company raised full-year outlook after a Q2 revenue beat late Thursday. Several analysts raised price targets on GH stock after the Q2 report, by as much as $50 a share, according to TheFly.com.